Jobs / United States / Astrazeneca Pharmaceuticals Lp
Director, BPM Evidence Publications CVRM
Astrazeneca Pharmaceuticals Lp · 🇺🇸 US - Gaithersburg - MD
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- What Astrazeneca Pharmaceuticals Lp paid sponsored hires in similar roles15 certified filings for “Associate Director Oncology Outcomes Research” (Medical Scientists, Except Epidemiologists) in MD: $126k–$185k, median $140k. Most were filed at wage level II (47%) — 2 lottery entries, ≈31% projected selection odds for cap-subject employers. Source: US Department of Labor LCA disclosure data (Oct 2025 – Jun 2026).
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Astrazeneca Pharmaceuticals Lp
The US Department of Labor certified 99 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 31 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Astrazeneca Pharmaceuticals Lp →
About the role
Main Duties and Responsibilities The Director, BPM Evidence Publications CVRM (Publications Lead) has direct accountability for the development and execution of strategic publication plans for global clinical registration studies (R&D) and non-clinical trial sources including HEOR, epidemiology, real-world evidence (RWE), payer, and non-interventional studies. The role drives timely , high-quality and compliant scientific communications by combining deep publications strategy and therapy-area expertise with the responsible use of advanced analytics and AI-enabled tool. As part of this role, the Publications Lead engages and collaborates with internal colleagues and external experts, investigators, journals, conference organizers and external bodies to deliver strategic publication and communication activities. The role also collaborates effectively with regional and country affiliates to develop and maintain integrated external scientific communications plans for regional and local healthcare professionals, payers, and patients. The Publications Lead is further responsible for ensuring ethical compliance with AZ standards and external publication guidelines of the publications plans and deliverables, and they ensure that all publications represent transparent and fair-balanced communications that enhance the Company’s external scientific reputation. Essential Requirements • Minimum of a Bachelor ’ s Degree in a scientific discipline with research experience with • Minimum 5 years of experience • Demonstrated experience in the publications field, or medical communications gained through working in the pharmaceutical industry or a medical communications agency . • Demonstrated project management experience . • Broad understanding of drug development process . • Working knowledge of AI/LLM co n cepts relevant to scientific publishing . • Demonstrated performance, budget, and resource management skills in a global organization • Excellent leadership and project management skills to deliver in a complex multidisciplinary environment . • Ability to establish and maintain professional relationships with external experts, investigators, journal editors and publishers and professional bodies . • Ability to effectively manage multiple stakeholders and projects to within budget . • Flexibility and adaptability to manage long-term activities in a constantly changing internal and external environment . Desirable Requirements • Relevant post-graduate degree . • Experience of working globally, cross-culturally and cross-functionally . • Proven experience designing and scaling AI-enabled workflow (e.g. prompt libraries, fine-tuning/evaluating LLMs) , with measurable impact , e.g. timelines. • CMPP Certification . • Working knowledge of iEnvision publication management system, and Microsoft Office products . • Strong therapeutic knowledge in cardiovascular, renal and / or metabolic therapy areas , with proven ability to adapt quickly to other therapeutic specialties . The annual base pay for this position ranges from 164,000 - 247,000 USD Annual (80% - 120%). Hourly and salaried non-exempt employees will also be paid overtime pay when working qualifying overtime hours. Base pay offered may vary depending on multiple individualized factors, including market location, job-related knowledge, skills, and experience. In addition, our positions offer a short-term incentive bonus opportunity; eligibility to participate in our equity-based long-term incentive program (salaried roles), to receive a retirement contribution (hourly roles), and commission payment eligibility (sales roles). Benefits offered included a